Navigation

Summary of Results

Health Topic:   Cardiovascular
Guidance:   Venous thromboembolism (surgical)
Description:   The summary of the withdrawn clinical guideline on Venous thromboembolism (surgical). It links to the withdrawn guidance and key documents.

NICE implementation uptake reports

Implementation uptake report Assessment Published Date Coverage

External literature

External literature Assessment Coverage

Faroug R, Konnuru S, Min S, Hussain F & Ampat G (2008) Venous thromboembolism prevention post neck of femur fractures - does it make a difference? Thrombosis Journal 6 (8)

Description: An audit of 123 case notes. The study found low molecular weight heparin (LMWH) tended only to be given during the hospital stay and only 6% of patients received LMWH for 4 weeks post surgery

Practice appears not to be in line with guidance Local

Sharif M et al (2008) Implementation of the NICE guidelines for Venous Thromboprophylaxis; A National Survey of Hip Surgeons Hip International

Description: A structured questionnaire was sent to all 250 British Hip Society members. Results found that the majority of surgeons had not specifically implemented the NICE guidance. For Total Hip Replacement 35% (58/166) of surgeons were adopting protocols in keeping with the subsequent recommendations by NICE, this increased to 44% (73/166) after publication of the recent guidelines

Doubts about or mixed impact in practice National

Jameson S.S et al (2010) The impact of national guidelines for the prophylaxis of venous thromboembolism on the complications of arthroplasty of the lower limb The Journal of Bone and Joint Surgery Vol 92-B, Issue 1, 123-129.

Description: NICE guidelines on prophylaxis for venous thromboembolism in orthopaedic surgery recommend that all patients be recommended low molecular weight heparin. The linked hospital episode statistics of 219,602 patients were examined to determine the rates of complications following lower limb arthroplasty for the 12-month periods prior to and post publication. There was a significant increase in the use of low molecular weight heparin (59.5% to 67.6%) following the publication of the guidelines.

Not graded Regional

This page was last updated: 01 January 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.